Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...
Eli Lilly came to the 44 th annual JP Morgan Healthcare Conference bolstered by a strong year. 1 While the looming patent cliff still impacts that company’s upcoming strategy, Lilly found itself in a ...
Investor's Business Daily on MSN
Nvidia eyes first breakout of 2026. These clues — and an innovative deal with Eli Lilly — bode well.
Nvidia eyes first breakout of 2026. These clues — and an innovative deal with Eli Lilly — bode well.
Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...
"The guiding principles of good AI practice in drug development are a first step of a renewed EU-US cooperation... to ...
At the JPMorgan Healthcare Conference in San Francisco, drugmakers signalled obesity drugs going mainstream, shifting from ...
Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...
The FDA has instructed Novo Nordisk and Eli Lilly to remove suicide risk warnings from their weight-loss medications after a ...
The Manila Times on MSN
AstraZeneca to acquire Modella AI to speed oncology drug research
AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
Eli Lilly partnership a "monumental effort" to speed up drug creation, despite Wall Street ignoring major AI shift.
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Investing.com -- Biogen Inc. ’s new at-home Alzheimer’s drug will provide an advantage over Eli Lilly Co. ’s competing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results